Please login to the form below

Not currently logged in
Email:
Password:

Eisai appoints Lynn Kramer chief clinical officer

Says newly created position will strengthen its research base

Lynn Kramer, EisaiEisai's US subsidiary has appointed Lynn Kramer to the newly created position of chief clinical officer of Eisai Product Creation Systems.

He will be responsible for the approval of protocol designs of studies and selection of study regions and clinical sites.

Eisai said the appointment, which will also see him provide oversight of the design of proof of concept (POC) Studies for each of Eisai's product creation units, would strengthen its clinical research.

In addition to his new responsibilities, Dr Kramer will continue to serve as president of Eisai's Neuroscience and General Medicine Product Creation Unit, a position he has held since 2009.

Dr Kramer joined Eisai in 2007 as executive vice president of global clinical research and his roles since then have included COO of Eisai Medical Research and president of the Scientific and Operational Clinical Support unit.

Prior to joining Eisai, Dr Krammer had already spent more two decades in the pharmaceutical industry, serving at companies such as PAR Pharmaceutical, Ciba Geigy and Novartis.

17th April 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics